Waldmann, Clark and Hale

Campath: from innovation to impact

01 August 2009

The path from innovation to impact can be long and complex. Here we describe the 30-year journey behind the development of a drug now being used to treat multiple sclerosis.

Read More

Cells make meal of Huntington's disease

08 May 2007
University of Cambridge researchers have developed a novel strategy to tackle neurodegenerative diseases such as Huntington's disease: encouraging an individuals own cells to “eat” the malformed proteins that lead to the disease.
Read More

Pages